Clinical use in COVID-19
Nitazoxanide is an antiparasitic agent which also has antiviral activities. Combined with hydroxychloroquine or azithromycin, a synergistic effect has been suggested as hydroxychloroquine and azithromycin inhibit viral entry and fusion, while nitazoxanide upregulates innate immune response to prevent on-going viral replication in COVID-19 (130).